A new, cellular-level approach to removing plaque build-up in the arteries could eventually lead to a cure for the chronic disease known as atherosclerosis, according to a researcher at Missouri S&T. The method uses nanoparticles that can be designed to deliver plaque-busting drugs to specific cells in arteries. The nanoparticles have an average diameter of 150 nanometers, about 1/500th the diameter of a human hair.
Read More »Dr. Steven Jung, an adjunct professor at Missouri S&T who developed a specialty glass used to speed healing of open wounds, has been named a Senior Member of the National Academy of Inventors, the NAI announced today (Tuesday, Aug. 11).
Read More »Researchers at Missouri S&T are developing an airborne-biohazard system that could help screeners spot air travelers with lung diseases due to coronavirus and other viruses. Professors in electrical and computer engineering are using machine learning to build a robust system to alert authorities to airborne biohazards as travelers pass through TSA security checkpoints.
Read More »An interdisciplinary team of Missouri S&T researchers is creating organ tissue samples using bioactive glass, stem cells and a 3D printer. The project could advance pharmaceutical testing and lead to a better understanding of how diseases affect human cells.
Read More »By combining their materials science expertise with large-scale medical research, Missouri S&T researchers hope to meet clinical demands for glass-related solutions through a new Center for Glass Science and Technology (CGST). The new center will build on Missouri S&T’s previous success in glass research, which includes the development of bioactive glasses to treat open wounds and cancers.
Read More »